Qui­et and con­fi­den­tial IPO reg­is­tra­tion? Who needs it. Au­to­lus shouts about its next big raise

Au­to­lus has launched a process to pri­vate­ly po­si­tion an IPO on Nas­daq, but de­cid­ed it doesn’t want to be so se­cre­tive about it.

The Lon­don-based cell ther­a­py trum­pet­ed “the con­fi­den­tial sub­mis­sion of a draft reg­is­tra­tion state­ment on Form F-1 to the U.S. Se­cu­ri­ties and Ex­change Com­mis­sion re­lat­ing to a po­ten­tial ini­tial pub­lic of­fer­ing of or­di­nary shares in the Unit­ed States.”

And they want you to know about it, even though the tim­ing, tar­get raise and terms are all up in the air.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER